BioMarin Pharmaceutical Inc.
BMRN
$66.05
$0.981.50%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -38.97% | 74.67% | 37.17% | 58.83% | 16.97% |
| Total Receivables | 23.98% | 22.29% | 37.50% | 1.64% | 23.82% |
| Inventory | 33.01% | -0.13% | 5.37% | 17.20% | 13.23% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 43.38% | 13.20% | -7.81% | 20.68% | 10.45% |
| Total Current Assets | 4.37% | 32.79% | 22.31% | 26.11% | 16.74% |
|
|
|||||
| Total Current Assets | 4.37% | 32.79% | 22.31% | 26.11% | 16.74% |
| Net Property, Plant & Equipment | -3.92% | -7.22% | -7.89% | -0.69% | -2.14% |
| Long-term Investments | 234.22% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 234.22% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 1,936.29% | -17.26% | -3.16% | -10.66% | -9.76% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -26.82% | 54.87% | 0.50% | 3.28% | -3.06% |
| Total Assets | 57.23% | 20.20% | 8.66% | 11.15% | 5.51% |
|
|
|||||
| Total Accounts Payable | 30.95% | 34.63% | 32.86% | 24.77% | 20.74% |
| Total Accrued Expenses | 81.24% | 25.20% | 19.03% | -7.08% | 8.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8,652.09% | 47.71% | 14.67% | -5.98% | -98.48% |
| Total Finance Division Other Current Liabilities | -25.36% | -18.45% | 32.14% | 66.97% | 111.33% |
| Total Other Current Liabilities | -25.36% | -18.45% | 32.14% | 66.97% | 111.33% |
| Total Current Liabilities | 143.19% | 26.26% | 25.05% | 11.57% | -35.89% |
|
|
|||||
| Total Current Liabilities | 143.19% | 26.26% | 25.05% | 11.57% | -35.89% |
| Long-Term Debt | 491.78% | 140.12% | 0.34% | 0.34% | 0.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 18.41% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 40.99% | 19.89% | 16.64% | 27.87% | 24.67% |
| Total Liabilities | 277.95% | 75.75% | 13.23% | 8.37% | -19.74% |
|
|
|||||
| Common Stock & APIC | 3.17% | 2.98% | 2.66% | 2.81% | 2.72% |
| Retained Earnings | 31.52% | 2,983.04% | 179.20% | 162.81% | 154.38% |
| Treasury Stock & Other | 64.41% | -284.19% | -147.56% | -539.99% | -471.80% |
| Total Common Equity | 4.89% | 7.23% | 7.58% | 11.88% | 14.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.89% | 7.23% | 7.58% | 11.88% | 14.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.89% | 7.23% | 7.58% | 11.88% | 14.01% |
|
|
|||||